<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37190097</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Reversing Dysdynamism to Interrupt Mitochondrial Degeneration in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1188</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12081188</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is one of several chronic neurodegenerative conditions in which mitochondrial abnormalities are posited to contribute to disease progression. Therapeutic options targeting mitochondria include enhancing metabolism, suppressing reactive oxygen production and disrupting mitochondria-mediated programmed cell death pathways. Herein is reviewed mechanistic evidence supporting a meaningful pathophysiological role for the constellation of abnormal mitochondrial fusion, fission and transport, collectively designated mitochondrial dysdynamism, in ALS. Following this is a discussion on preclinical studies in ALS mice that seemingly validate the idea that normalizing mitochondrial dynamism can delay ALS by interrupting a vicious cycle of mitochondrial degeneration, leading to neuronal die-back and death. Finally, the relative benefits of suppressing mitochondrial fusion vs. enhancing mitochondrial fusion in ALS are speculated upon, and the paper concludes with the prediction that the two approaches could be additive or synergistic, although a side-by-side comparative trial may be challenging to perform.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dorn</LastName><ForeName>Gerald W</ForeName><Initials>GW</Initials><Suffix>2nd</Suffix><Identifier Source="ORCID">0000-0002-8995-1624</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine (Pharmacogenomics), Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R42 NS113642</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R42 NS115184</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL135736</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063154" MajorTopicYN="N">Mitochondrial Dynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mitochondrial fission</Keyword><Keyword MajorTopicYN="N">mitochondrial fusion</Keyword><Keyword MajorTopicYN="N">mitochondrial transport</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword></KeywordList><CoiStatement>GWD is the inventor on multiple patents awarded and pending describing therapeutic use of mitofusin activators in neurodegenerative disease. He is the founder and a consultant for Mitochondria in Motion, Inc. and Mitochondria Emotion Inc., and may benefit financially if mitofusin activators are approved for human use.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37190097</ArticleId><ArticleId IdType="pmc">PMC10136928</ArticleId><ArticleId IdType="doi">10.3390/cells12081188</ArticleId><ArticleId IdType="pii">cells12081188</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasko D., Salmon D., Gamst A., Olichney J., Thal L.J., Silbert L., Kaye J., Brooks P., Adonay R., Craig U.K., et al. Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE. Neurology. 2007;68:1772&#x2013;1781. doi: 10.1212/01.wnl.0000262028.16738.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000262028.16738.64</ArticleId><ArticleId IdType="pubmed">17515539</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner R.D., Kamins K.G., Feussner J.R., Grambow S.C., Hoff-Lindquist J., Harati Y., Mitsumoto H., Pascuzzi R., Spencer P.S., Tim R., et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61:742&#x2013;749. doi: 10.1212/01.WNL.0000069922.32557.CA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000069922.32557.CA</ArticleId><ArticleId IdType="pubmed">14504315</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Powell J.F., Andersen P.M., Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351. doi: 10.1002/humu.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Detmer S.A., Chan D.C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 2007;176:405&#x2013;414. doi: 10.1083/jcb.200611080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200611080</ArticleId><ArticleId IdType="pmc">PMC2063976</ArticleId><ArticleId IdType="pubmed">17296794</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang X., Walton E.K., Zablocka B., Baloh R.H., Shy M.E., Dorn G.W., 2nd Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation. Cells. 2022;11:1053. doi: 10.3390/cells11061053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11061053</ArticleId><ArticleId IdType="pmc">PMC8947610</ArticleId><ArticleId IdType="pubmed">35326504</ArticleId></ArticleIdList></Reference><Reference><Citation>Olesen M.A., Villavicencio-Tejo F., Quintanilla R.A. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. Transl. Neurodegener. 2022;11:36. doi: 10.1186/s40035-022-00308-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00308-y</ArticleId><ArticleId IdType="pmc">PMC9251940</ArticleId><ArticleId IdType="pubmed">35787292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kann O., Kov&#xe1;cs R. Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 2007;292:C641&#x2013;C657. doi: 10.1152/ajpcell.00222.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00222.2006</ArticleId><ArticleId IdType="pubmed">17092996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Cookson M.R., Taylor R.W., Turnbull D.M., Chrzanowska-Lightowlers Z.M., Dong L., Figlewicz D.A., Shaw P.J. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain. 2002;125:1522&#x2013;1533. doi: 10.1093/brain/awf167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf167</ArticleId><ArticleId IdType="pubmed">12077002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos I.G., Bacman S.R., Hernandez D., Oca-Cossio J., Arias L.J., Perez-Pinzon M.A., Bradley W.G., Moraes C.T. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 2005;25:164&#x2013;172. doi: 10.1523/JNEUROSCI.3829-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3829-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725219</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Z.H., Cai Q. Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 2012;13:77&#x2013;93. doi: 10.1038/nrn3156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3156</ArticleId><ArticleId IdType="pmc">PMC4962561</ArticleId><ArticleId IdType="pubmed">22218207</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath S., Sharma R., Gupta R., Ast T., Chan C., Durham T.J., Goodman R.P., Grabarek Z., Haas M.E., Hung W.H.W., et al. MitoCarta3.0: An updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49:D1541&#x2013;D1547. doi: 10.1093/nar/gkaa1011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1011</ArticleId><ArticleId IdType="pmc">PMC7778944</ArticleId><ArticleId IdType="pubmed">33174596</ArticleId></ArticleIdList></Reference><Reference><Citation>Korr H., Kurz C., Seidler T.O., Sommer D., Schmitz C. Mitochondrial DNA synthesis studied autoradiographically in various cell types in vivo. Braz. J. Med. Biol. Res. 1998;31:289&#x2013;298. doi: 10.1590/S0100-879X1998000200012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-879X1998000200012</ArticleId><ArticleId IdType="pubmed">9686151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatre L., Ricchetti M. Prevalent coordination of mitochondrial DNA transcription and initiation of replication with the cell cycle. Nucleic Acids Res. 2013;41:3068&#x2013;3078. doi: 10.1093/nar/gkt015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt015</ArticleId><ArticleId IdType="pmc">PMC3597681</ArticleId><ArticleId IdType="pubmed">23345615</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne B.A., Chinnery P.F. Mitochondrial dysfunction in aging: Much progress but many unresolved questions. Biochim. Biophys. Acta. 2015;1847:1347&#x2013;1353. doi: 10.1016/j.bbabio.2015.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2015.05.022</ArticleId><ArticleId IdType="pmc">PMC4580208</ArticleId><ArticleId IdType="pubmed">26050973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao R.Z., Jiang S., Zhang L., Yu Z.B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review) Int. J. Mol. Med. 2019;44:3&#x2013;15. doi: 10.3892/ijmm.2019.4188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2019.4188</ArticleId><ArticleId IdType="pmc">PMC6559295</ArticleId><ArticleId IdType="pubmed">31115493</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S., Jeong Y.Y., Sheshadri P., Su X., Cai Q. Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance. EMBO Rep. 2020;21:e49801. doi: 10.15252/embr.201949801.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949801</ArticleId><ArticleId IdType="pmc">PMC7507095</ArticleId><ArticleId IdType="pubmed">32627320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampinen R., Belaya I., Saveleva L., Liddell J.R., Rait D., Huuskonen M.T., Giniatullina R., Sorvari A., Soppela L., Mikhailov N., et al. Neuron-astrocyte transmitophagy is altered in Alzheimer&#x2019;s disease. Neurobiol. Dis. 2022;170:105753. doi: 10.1016/j.nbd.2022.105753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105753</ArticleId><ArticleId IdType="pubmed">35569719</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz T.L. Mitochondrial trafficking in neurons. Cold Spring Harb. Perspect. Biol. 2013;5:a011304. doi: 10.1101/cshperspect.a011304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a011304</ArticleId><ArticleId IdType="pmc">PMC3660831</ArticleId><ArticleId IdType="pubmed">23732472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.Y., Sheng Z.H. Regulation of mitochondrial transport in neurons. Exp. Cell Res. 2015;334:35&#x2013;44. doi: 10.1016/j.yexcr.2015.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.01.004</ArticleId><ArticleId IdType="pmc">PMC4433773</ArticleId><ArticleId IdType="pubmed">25612908</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt E.L., Ludlam A.V., Tan Z., Cianfrocco M.A. Miro: A molecular switch at the center of mitochondrial regulation. Protein Sci. 2020;29:1269&#x2013;1284. doi: 10.1002/pro.3839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3839</ArticleId><ArticleId IdType="pmc">PMC7255519</ArticleId><ArticleId IdType="pubmed">32056317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Ultrastructural study of the synapses of central chromatolytic anterior horn cells in motor neuron disease. J. Neuropathol. Exp. Neurol. 1996;55:932&#x2013;939. doi: 10.1097/00005072-199608000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199608000-00009</ArticleId><ArticleId IdType="pubmed">8759783</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007;16:2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Horie Y., Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114:633&#x2013;639. doi: 10.1007/s00401-007-0299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0299-1</ArticleId><ArticleId IdType="pubmed">17929040</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wang W., Siedlak S.L., Liu Y., Liu J., Jiang K., Perry G., Zhu X., Wang X. Miro1 deficiency in amyotrophic lateral sclerosis. Front. Aging Neurosci. 2015;7:100. doi: 10.3389/fnagi.2015.00100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00100</ArticleId><ArticleId IdType="pmc">PMC4443026</ArticleId><ArticleId IdType="pubmed">26074815</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A., Bauer C.S., Cohen R.N., Webster C.P., De Vos K.J. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum. Mol. Genet. 2017;26:4668&#x2013;4679. doi: 10.1093/hmg/ddx348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pmc">PMC5886184</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 1999;46:787&#x2013;790. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D.C. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 2006;22:79&#x2013;99. doi: 10.1146/annurev.cellbio.22.010305.104638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.22.010305.104638</ArticleId><ArticleId IdType="pubmed">16704336</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008;9:505&#x2013;518. doi: 10.1038/nrn2417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2417</ArticleId><ArticleId IdType="pmc">PMC2711514</ArticleId><ArticleId IdType="pubmed">18568013</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyderman H., Chen T. Mitochondrial dysfunction in amyotrophic lateral sclerosis&#x2014;A valid pharmacological target? Br. J. Pharmacol. 2014;171:2191&#x2013;2205. doi: 10.1111/bph.12476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12476</ArticleId><ArticleId IdType="pmc">PMC3976630</ArticleId><ArticleId IdType="pubmed">24148000</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.Y., Atkin J.D., Farg M., Walker A.K., Horne M.K., Nagley P. Bim links ER stress and apoptosis in cells expressing mutant SOD1 associated with amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e35413. doi: 10.1371/journal.pone.0035413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035413</ArticleId><ArticleId IdType="pmc">PMC3327676</ArticleId><ArticleId IdType="pubmed">22523592</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.R., Yang E.J. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations. Diagnostics. 2021;11:1546. doi: 10.3390/diagnostics11091546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091546</ArticleId><ArticleId IdType="pmc">PMC8465946</ArticleId><ArticleId IdType="pubmed">34573888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Chan D.C. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum. Mol. Genet. 2009;18:R169&#x2013;R176. doi: 10.1093/hmg/ddp326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp326</ArticleId><ArticleId IdType="pmc">PMC2758711</ArticleId><ArticleId IdType="pubmed">19808793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari P., Song M., Chen Y., Burelle Y., Dorn G.W., 2nd Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin. Circ. Res. 2014;114:257&#x2013;265. doi: 10.1161/CIRCRESAHA.114.302734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.302734</ArticleId><ArticleId IdType="pmc">PMC4392818</ArticleId><ArticleId IdType="pubmed">24192653</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H., Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 1997;42:644&#x2013;654. doi: 10.1002/ana.410420416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S., Nelson K., Luo M., Paulson H., Sch&#xf6;neich C., et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Investig. 2008;118:659&#x2013;670. doi: 10.1172/JCI34060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34060</ArticleId><ArticleId IdType="pmc">PMC2213375</ArticleId><ArticleId IdType="pubmed">18219391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Kong Q., Shan X., Tian G., Ilieva H., Cleveland D.W., Rothstein J.D., Borchelt D.R., Wong P.C., Lin C.L. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS ONE. 2008;3:e2849. doi: 10.1371/journal.pone.0002849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002849</ArticleId><ArticleId IdType="pmc">PMC2481395</ArticleId><ArticleId IdType="pubmed">18682740</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free. Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Mochly-Rosen D. Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases. Pharmacol. Res. 2018;138:2&#x2013;15. doi: 10.1016/j.phrs.2018.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.08.010</ArticleId><ArticleId IdType="pmc">PMC6263811</ArticleId><ArticleId IdType="pubmed">30144530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Houseweart M.K., Brown R.H., Jr., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:13901&#x2013;13906. doi: 10.1073/pnas.240305897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.240305897</ArticleId><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson J., Fong K.S., Hansson M.J., Elm&#xe9;r E., Csiszar K., Keep M.F. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosurg. 2004;101:128&#x2013;137. doi: 10.3171/jns.2004.101.1.0128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2004.101.1.0128</ArticleId><ArticleId IdType="pubmed">15255263</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., Chang Q. The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice. Exp. Neurol. 2009;218:333&#x2013;346. doi: 10.1016/j.expneurol.2009.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.02.015</ArticleId><ArticleId IdType="pmc">PMC2710399</ArticleId><ArticleId IdType="pubmed">19272377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A.R., Walters R., Waldron F.M., Pal S., Selvaraj B.T., Macleod M.R., Hardingham G.E., Chandran S., Gregory J.M. Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Brain Commun. 2019;1:fcz009. doi: 10.1093/braincomms/fcz009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz009</ArticleId><ArticleId IdType="pmc">PMC7056361</ArticleId><ArticleId IdType="pubmed">32133457</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Li B., Flanagan S.W., Oberley L.W., Gozal D., Qiu M. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. J. Neurochem. 2002;80:488&#x2013;500. doi: 10.1046/j.0022-3042.2001.00720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00720.x</ArticleId><ArticleId IdType="pubmed">11905995</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P., Cassina A., Pehar M., Castellanos R., Gandelman M., de Le&#xf3;n A., Robinson K.M., Mason R.P., Beckman J.S., Barbeito L., et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: Prevention by mitochondrial-targeted antioxidants. J. Neurosci. 2008;28:4115&#x2013;4122. doi: 10.1523/JNEUROSCI.5308-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5308-07.2008</ArticleId><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Mart&#xed;nez-Palma L., Souza J.M., Bolatto C., Rodr&#xed;guez-Bottero S., Logan A., Smith R.A., Murphy M.P., Barbeito L., et al. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free. Radic. Biol. Med. 2014;70:204&#x2013;213. doi: 10.1016/j.freeradbiomed.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Ona V.O., Gu&#xe9;gan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335&#x2013;339. doi: 10.1126/science.288.5464.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5464.335</ArticleId><ArticleId IdType="pubmed">10764647</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukosavic S., Stefanis L., Jackson-Lewis V., Gu&#xe9;gan C., Romero N., Chen C., Dubois-Dauphin M., Przedborski S. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2000;20:9119&#x2013;9125. doi: 10.1523/JNEUROSCI.20-24-09119.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-24-09119.2000</ArticleId><ArticleId IdType="pmc">PMC6773037</ArticleId><ArticleId IdType="pubmed">11124989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathasivam S., Ince P.G., Shaw P.J. Apoptosis in amyotrophic lateral sclerosis: A review of the evidence. Neuropathol. Appl. Neurobiol. 2001;27:257&#x2013;274. doi: 10.1046/j.0305-1846.2001.00332.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0305-1846.2001.00332.x</ArticleId><ArticleId IdType="pubmed">11532157</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J.B., Girgenrath M. The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy. Trends Mol. Med. 2006;12:279&#x2013;286. doi: 10.1016/j.molmed.2006.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2006.04.003</ArticleId><ArticleId IdType="pubmed">16650805</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesa M., Van der Bliek A., Shirihai O.S. To Fis or not to Fuse? This is the question! EMBO J. 2019;38:e101839. doi: 10.15252/embj.2019101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019101839</ArticleId><ArticleId IdType="pmc">PMC6463207</ArticleId><ArticleId IdType="pubmed">30936092</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G., Yi J., Ma C., Xiao Y., Yi F., Yu T., Zhou J. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE. 2013;8:e82112. doi: 10.1371/journal.pone.0082112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082112</ArticleId><ArticleId IdType="pmc">PMC3855744</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.M., Youn S.W., Sudhahar V., Das A., Chandhri R., Cuervo Grajal H., Kweon J., Leanhart S., He L., Toth P.T., et al. Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence. Cell Rep. 2018;23:3565&#x2013;3578. doi: 10.1016/j.celrep.2018.05.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.054</ArticleId><ArticleId IdType="pmc">PMC6324937</ArticleId><ArticleId IdType="pubmed">29924999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattie S., Riemer J., Wideman J.G., McBride H.M. A new mitofusin topology places the redox-regulated C terminus in the mitochondrial intermembrane space. J. Cell Biol. 2018;217:507&#x2013;515. doi: 10.1083/jcb.201611194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201611194</ArticleId><ArticleId IdType="pmc">PMC5800796</ArticleId><ArticleId IdType="pubmed">29212658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzano A., Sebastian D., Segales J., Palacin M. The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery? Curr. Opin. Drug Discov. Dev. 2009;12:597&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">19736619</ArticleId></ArticleIdList></Reference><Reference><Citation>Burte F., Carelli V., Chinnery P.F., Yu-Wai-Man P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 2015;11:11&#x2013;24. doi: 10.1038/nrneurol.2014.228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.228</ArticleId><ArticleId IdType="pubmed">25486875</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn G.W., 2nd, Vega R.B., Kelly D.P. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29:1981&#x2013;1991. doi: 10.1101/gad.269894.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.269894.115</ArticleId><ArticleId IdType="pmc">PMC4604339</ArticleId><ArticleId IdType="pubmed">26443844</ArticleId></ArticleIdList></Reference><Reference><Citation>Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: The bioenergetic view. Biochim. Biophys. Acta BBA-Bioenerg. 2008;1777:1092&#x2013;1097. doi: 10.1016/j.bbabio.2008.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2008.05.001</ArticleId><ArticleId IdType="pmc">PMC3809017</ArticleId><ArticleId IdType="pubmed">18519024</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010;11:872&#x2013;884. doi: 10.1038/nrm3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3013</ArticleId><ArticleId IdType="pubmed">21102612</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalska B., Duszy&#x144;ski J., Szyma&#x144;ski J. Mechanism of mitochondrial fission&#x2014;Structure and function of Drp1 protein. Postepy Biochem. 2016;62:127&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">28132464</ArticleId></ArticleIdList></Reference><Reference><Citation>James D.I., Parone P.A., Mattenberger Y., Martinou J.C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 2003;278:36373&#x2013;36379. doi: 10.1074/jbc.M303758200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303758200</ArticleId><ArticleId IdType="pubmed">12783892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chan D.C. Structural basis for recruitment of mitochondrial fission complexes by Fis1. Proc. Natl. Acad. Sci. USA. 2007;104:18526&#x2013;18530. doi: 10.1073/pnas.0706441104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0706441104</ArticleId><ArticleId IdType="pmc">PMC2141810</ArticleId><ArticleId IdType="pubmed">17998537</ArticleId></ArticleIdList></Reference><Reference><Citation>Otera H., Wang C., Cleland M.M., Setoguchi K., Yokota S., Youle R.J., Mihara K. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 2010;191:1141&#x2013;1158. doi: 10.1083/jcb.201007152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201007152</ArticleId><ArticleId IdType="pmc">PMC3002033</ArticleId><ArticleId IdType="pubmed">21149567</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Chan D.C. The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1. Mol. Biol. Cell. 2015;26:4466&#x2013;4477. doi: 10.1091/mbc.E15-08-0591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E15-08-0591</ArticleId><ArticleId IdType="pmc">PMC4666140</ArticleId><ArticleId IdType="pubmed">26446846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L., Neuber-Hess M., Mewburn J., Dasgupta A., Dunham-Snary K., Wu D., Chen K.H., Hong Z., Sharp W.W., Kutty S., et al. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. J. Mol. Med. 2017;95:381&#x2013;393. doi: 10.1007/s00109-017-1522-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-017-1522-8</ArticleId><ArticleId IdType="pmc">PMC5390778</ArticleId><ArticleId IdType="pubmed">28265681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R., Jin S.B., Lendahl U., Nist&#xe9;r M., Zhao J. Human Fis1 regulates mitochondrial dynamics through inhibition of the fusion machinery. EMBO J. 2019;38:e99748. doi: 10.15252/embj.201899748.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201899748</ArticleId><ArticleId IdType="pmc">PMC6463211</ArticleId><ArticleId IdType="pubmed">30842096</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.J., Suh Y.L. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct. Pathol. 2002;26:3&#x2013;7. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G., Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion. 2005;5:77&#x2013;87. doi: 10.1016/j.mito.2005.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2005.01.002</ArticleId><ArticleId IdType="pubmed">16050975</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P.H., Reddy T.P., Manczak M., Calkins M.J., Shirendeb U., Mao P. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res. Rev. 2011;67:103&#x2013;118. doi: 10.1016/j.brainresrev.2010.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2010.11.004</ArticleId><ArticleId IdType="pmc">PMC3061980</ArticleId><ArticleId IdType="pubmed">21145355</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Yamashita T., Tian F., Morimoto N., Ikeda Y., Deguchi K., Abe K. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr. Neurovascular Res. 2013;10:222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Song Y., Kincaid B., Bossy B., Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy-Stone A., Chipuk J.E., Ingerman E., Song C., Yoo C., Kuwana T., Kurth M.J., Shaw J.T., Hinshaw J.E., Green D.R., et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell. 2008;14:193&#x2013;204. doi: 10.1016/j.devcel.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2007.11.019</ArticleId><ArticleId IdType="pmc">PMC2267902</ArticleId><ArticleId IdType="pubmed">18267088</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X., Qvit N., Su Y.C., Mochly-Rosen D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 2013;126:789&#x2013;802. doi: 10.1242/jcs.114439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.114439</ArticleId><ArticleId IdType="pmc">PMC3619809</ArticleId><ArticleId IdType="pubmed">23239023</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Saw N.L., Vogel H., Cunnigham A.D., Shamloo M., Mochly-Rosen D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10:e8166. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordt E.A., Clerc P., Roelofs B.A., Saladino A.J., Tretter L., Adam-Vizi V., Cherok E., Khalil A., Yadava N., Ge S.X., et al. The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species. Dev. Cell. 2017;40:583&#x2013;594.e6. doi: 10.1016/j.devcel.2017.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2017.02.020</ArticleId><ArticleId IdType="pmc">PMC5398851</ArticleId><ArticleId IdType="pubmed">28350990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz A., Alberdi E., Matute C. Mitochondrial Division Inhibitor 1 (mdivi-1) Protects Neurons against Excitotoxicity through the Modulation of Mitochondrial Function and Intracellular Ca(2+) Signaling. Front. Mol. Neurosci. 2018;11:3. doi: 10.3389/fnmol.2018.00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00003</ArticleId><ArticleId IdType="pmc">PMC5776080</ArticleId><ArticleId IdType="pubmed">29386996</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Disatnik M.H., Monbureau M., Shamloo M., Mochly-Rosen D., Qi X. Inhibition of mitochondrial fragmentation diminishes Huntington&#x2019;s disease-associated neurodegeneration. J. Clin. Investig. 2013;123:5371&#x2013;5388. doi: 10.1172/JCI70911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI70911</ArticleId><ArticleId IdType="pmc">PMC3859413</ArticleId><ArticleId IdType="pubmed">24231356</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha A.G., Franco A., Krezel A.M., Rumsey J.M., Alberti J.M., Knight W.C., Biris N., Zacharioudakis E., Janetka J.W., Baloh R.H., et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science. 2018;360:336&#x2013;341. doi: 10.1126/science.aao1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao1785</ArticleId><ArticleId IdType="pmc">PMC6109362</ArticleId><ArticleId IdType="pubmed">29674596</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Dang X., Franco A., Dorn G.W. Reciprocal Regulation of Mitofusin 2-Mediated Mitophagy and Mitochondrial Fusion by Different PINK1 Phosphorylation Events. Front. Cell Dev. Biol. 2022;10:868465. doi: 10.3389/fcell.2022.868465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.868465</ArticleId><ArticleId IdType="pmc">PMC9133611</ArticleId><ArticleId IdType="pubmed">35646911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuchner S., Mersiyanova I.V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., Zappia M., Nelis E., Patitucci A., Senderek J., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004;36:449&#x2013;451. doi: 10.1038/ng1341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1341</ArticleId><ArticleId IdType="pubmed">15064763</ArticleId></ArticleIdList></Reference><Reference><Citation>Feely S.M., Laura M., Siskind C.E., Sottile S., Davis M., Gibbons V.S., Reilly M.M., Shy M.E. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology. 2011;76:1690&#x2013;1696. doi: 10.1212/WNL.0b013e31821a441e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821a441e</ArticleId><ArticleId IdType="pmc">PMC3100135</ArticleId><ArticleId IdType="pubmed">21508331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombelli F., Stojkovic T., Dubourg O., Echaniz-Laguna A., Tardieu S., Larcher K., Amati-Bonneau P., Latour P., Vignal O., Cazeneuve C., et al. Charcot-Marie-Tooth disease type 2A: From typical to rare phenotypic and genotypic features. JAMA Neurol. 2014;71:1036&#x2013;1042. doi: 10.1001/jamaneurol.2014.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.629</ArticleId><ArticleId IdType="pubmed">24957169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanna C., Ghelli A., Porcelli A.M., Karbowski M., Youle R.J., Schimpf S., Wissinger B., Pinti M., Cossarizza A., Vidoni S., et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain. 2008;131:352&#x2013;367. doi: 10.1093/brain/awm335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm335</ArticleId><ArticleId IdType="pubmed">18222991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouzier C., Bannwarth S., Chaussenot A., Chevrollier A., Verschueren A., Bonello-Palot N., Fragaki K., Cano A., Pouget J., Pellissier J.F., et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy &#x2018;plus&#x2019; phenotype. Brain. 2012;135:23&#x2013;34. doi: 10.1093/brain/awr323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr323</ArticleId><ArticleId IdType="pubmed">22189565</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi L., Marcotulli C., Storti E., Tessa A., Serrao M., Parisi V., Santorelli F.M., Pierelli F., Casali C. Acute optic neuropathy associated with a novel MFN2 mutation. J. Neurol. 2015;262:1678&#x2013;1680. doi: 10.1007/s00415-015-7756-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7756-x</ArticleId><ArticleId IdType="pubmed">25957633</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerriero S., D&#x2019;Oria F., Rossetti G., Favale R.A., Zoccolella S., Alessio G., Petruzzella V. CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity. Int. Med. Case Rep. J. 2020;13:41&#x2013;45. doi: 10.2147/IMCRJ.S237620.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IMCRJ.S237620</ArticleId><ArticleId IdType="pmc">PMC7039061</ArticleId><ArticleId IdType="pubmed">32110117</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Gao J., Liu J., Siedlak S.L., Torres S., Fujioka H., Huntley M.L., Jiang Y., Ji H., Yan T., et al. Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles. Cell Metab. 2018;28:400&#x2013;414.e408. doi: 10.1016/j.cmet.2018.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.06.011</ArticleId><ArticleId IdType="pmc">PMC6125186</ArticleId><ArticleId IdType="pubmed">30017354</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-L&#xf3;pez I., Sancho-Bielsa F.J., Engel T., Garc&#xed;a A.G., Pad&#xed;n J.F. Progressive Mitochondrial SOD1(G93A) Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:8194. doi: 10.3390/ijms22158194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158194</ArticleId><ArticleId IdType="pmc">PMC8347639</ArticleId><ArticleId IdType="pubmed">34360957</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco A., Kitsis R.N., Fleischer J.A., Gavathiotis E., Kornfeld O.S., Gong G., Biris N., Benz A., Qvit N., Donnelly S.K., et al. Correcting mitochondrial fusion by manipulating mitofusin conformations. Nature. 2016;540:74&#x2013;79. doi: 10.1038/nature20156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20156</ArticleId><ArticleId IdType="pmc">PMC5315023</ArticleId><ArticleId IdType="pubmed">27775718</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang X., Zhang L., Franco A., Li J., Rocha A.G., Devanathan S., Dolle R.E., Bernstein P.R., Dorn G.W., 2nd Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases. J. Med. Chem. 2020;63:7033&#x2013;7051. doi: 10.1021/acs.jmedchem.0c00366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c00366</ArticleId><ArticleId IdType="pmc">PMC7731667</ArticleId><ArticleId IdType="pubmed">32506913</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco A., Dang X., Walton E.K., Ho J.N., Zablocka B., Ly C., Miller T.M., Baloh R.H., Shy M.E., Yoo A.S., et al. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A. eLife. 2020;9:e61119. doi: 10.7554/eLife.61119.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61119</ArticleId><ArticleId IdType="pmc">PMC7655101</ArticleId><ArticleId IdType="pubmed">33074106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang X., Williams S.B., Devanathan S., Franco A., Fu L., Bernstein P.R., Walters D., Dorn G.W., 2nd Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity. J. Med. Chem. 2021;64:12506&#x2013;12524. doi: 10.1021/acs.jmedchem.1c00163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.1c00163</ArticleId><ArticleId IdType="pmc">PMC8632069</ArticleId><ArticleId IdType="pubmed">34415150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Dang X., Franco A., Zhao H., Dorn G.W. Piperine Derivatives Enhance Fusion and Axonal Transport of Mitochondria by Activating Mitofusins. Chemistry. 2022;4:655&#x2013;668. doi: 10.3390/chemistry4030047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/chemistry4030047</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco A., Dang X., Zhang L., Molinoff P.B., Dorn G.W., 2nd Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A. J. Pharmacol. Exp. Ther. 2022;383:137&#x2013;148. doi: 10.1124/jpet.122.001332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001332</ArticleId><ArticleId IdType="pmc">PMC9553116</ArticleId><ArticleId IdType="pubmed">36507849</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang X., Zhang L., Franco A., Dorn G.W. Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis. Hum. Mol. Genet. 2022;32:1208&#x2013;1222. doi: 10.1093/hmg/ddac287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac287</ArticleId><ArticleId IdType="pmc">PMC10026224</ArticleId><ArticleId IdType="pubmed">36416308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., McCaffery J.M., Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell. 2007;130:548&#x2013;562. doi: 10.1016/j.cell.2007.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.06.026</ArticleId><ArticleId IdType="pubmed">17693261</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham A.H., Meng S., Chu Q.N., Chan D.C. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum. Mol. Genet. 2012;21:4817&#x2013;4826. doi: 10.1093/hmg/dds311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds311</ArticleId><ArticleId IdType="pmc">PMC3607482</ArticleId><ArticleId IdType="pubmed">22859504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Sterky F.H., Mourier A., Terzioglu M., Cullheim S., Olson L., Larsson N.G. Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum. Mol. Genet. 2012;21:4827&#x2013;4835. doi: 10.1093/hmg/dds352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds352</ArticleId><ArticleId IdType="pubmed">22914740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Wang J., Bonamy G.M., Meeusen S., Brusch R.G., Turk C., Yang P., Schultz P.G. A small molecule promotes mitochondrial fusion in mammalian cells. Angew. Chem. Int. Ed. Engl. 2012;51:9302&#x2013;9305. doi: 10.1002/anie.201204589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201204589</ArticleId><ArticleId IdType="pubmed">22907892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>